Structural

Prediction of Early and Long-term Mortality After Transcatheter Aortic Valve Implantation in Australia: A Machine-learning Based Risk Prediction Model (PREDICT-TAVI)

AI-Driven Prediction of TAVR Expansion: A Comparative Study with Traditional Models

TAVR Device Selection Considerations (SMART)

SAVR vs. TAVR Strategy Trials (PARTNER 3 and RHEIA)

AVR in Asymptomatic Severe Aortic Stenosis: The EARLY TAVR Trial and Beyond

Late Clinical Outcomes After TAVR: Impact of Frailty and Social Vulnerability in a “Real World” Administrative Claims Database

Lessons From NOTION II: Are Large RCTS the Next Step?

Building the Case for an All-Comers RCT in AR: Surgery vs. Transcatheter Replacement

Late Health Status Outcomes with Patient-Prosthesis Mismatch After AVR in the PARTNER Trials

Rationale and Status of “At Risk” Moderate AS Trials (PROGRESS and EXPAND TAVR II)

Perspectives From TAVR UNLOAD

Do We Need Advanced Imaging to Phenotype Asymptomatic AS Patients? Lessons From the EVOLVED Trial

Will EARLY TAVR Change the Guidelines: Not Much, We Need Stronger Evidence!

Managing AS Patients Before Symptoms or Severe Disease: Insights Into Current Practice

Will EARLY TAVR Change the Guidelines: Yes, Most Definitely!

Outcomes of Patients With New Left Bundle Branch Block Following Transcatheter Aortic Valve Replacement: Insights From the NCDR STS/ACC TVT Registry

Atrioventricular Conduction System Changes During Transcatheter Aortic Valve Replacement (TAVR): Anatomic and Electrophysiologic Predictors of Heart Block in Prospective 400 Patient EPS/TAVR Study

Trancatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)

Cerebral Microbleeds During Transcatheter Aortic Valve Replacement: A Prospective Magnetic Resonance Imaging Study Cohort

Cardiac Output, Cerebral Blood Flow and Cognitive Functioning in Patients Undergoing Transcatheter Aortic Valve Implantation

Prophylactic Antithrombotic Therapy After TAVR

Pharmacotherapy to Slow AS Progression and Protect the Heart

Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial

Moderate AS With Cardiac Damage: The PROGRESS Trial

Moderate AS With Heart Failure: TAVR UNLOAD

EARLY TAVR

EVOLVED: CMR As an Early Marker of Risk

TAVR vs SAVR in Low Gradient AS: Evidence Updates

Five-year Echocardiographic Outcomes From The PARTNER 3 Low-risk Randomized Trial

Importance of Patient Reported Outcomes

An Echo Deep Dive of the PARTNER 5-Year Study

Important Secondary Endpoints From the PARTNER 3 5-YEAR STUDY

Perspectives on Mortality in the PARNTER 5-Year Study

ALIGN-AR Trial: Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement in High Risk Patients With Symptomatic Severe Native Aortic Regurgitation

Four-Year Outcomes From the EVOLUT Low Risk Trial

Five-Year Clinical and Echocardiographic Outcomes From The PARTNER 3 Low-Risk Randomized Trial

Comparison of Two Self-Expanding Transcatheter Heart Valves for Degenerated Surgical Bioprostheses: The AVENGER Multi-Center Registry

Moderate AS With Heart Failure: UNLOAD and Beyond

Prognostic Value of Tricuspid Valve Gradient After Transcatheter Edge-To-Edge Repair: Insights from the TriValve Registry

SPOTLIGHT LECTURE: Failed TAVR Management -Lessons Learned From Registry Experiences

Clinical Data for the ACURATE Platform

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Pharmacotherapy to Prevent Calcific Aortic Stenosis: Novel Targets and Novel Study Methodologies

Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

Using CMR Imaging to Identify High-Risk Severe AS Patients (Introduction to the EVOLVED Study)

SPOTLIGHT LECTURE Staging of Aortic Stenosis According to Cardiac Dysfunction: Recent Updates

How Do We Communicate Known vs Uncertain Risks and Benefits of TAVR to Younger (<65 yo) Patients?

SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments

Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

Sensor-Guided TAVR Initial experience with the SavvyWire: Post-Market Registry of the First 60 Cases

ShortCut Dedicated Aortic Leaflet Splitting Device: Clinical Experience and Emerging Indications

Can Scoring the Calcified Aortic Valve Defer the Need for Permanent Implant (Leaflex): Technology and Clinical Update

Aortic Valve Lithotripsy Before TAVR: Early Human Clinical Experience

TAVR Explant: What Every Interventionalist (and Surgeon) Needs to Know

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Surgical ADVANCEMENTS in Aortic Valve Regurgitation: When to… Repair vs. Ross vs. Replace with Root Management?

Intersection of Guidelines and Clinical practice : Meaningful Guardrails Provide a Necessary Framework

Update on the Evidence – Registries are Enough

Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies